Medical News

RSS

Oxygen Biotherapeutics to commence study to determine efficacy of Dermacyte in relieving Histamine induced pruritus

Oxygen Biotherapeutics, Inc. has announced that enrollment for the company’s first dermatological study will begin later this month at St. John’s Medical College Hospital in Bangalore, India. The company received formal approval from the hospital’s Ethics Review Board in December. This study is the first of a series of trials scheduled for 2012 to explore the efficacy of Dermacyte to treat a variety of dermatological conditions, such as allergic contact dermatitis, psoriasis and acne.

9 Jan 2012

Novel target in artery plaque identified as potential therapeutic intervention

A new study by NYU Langone Medical Center researchers identified a new culprit that leads to atherosclerosis, the accumulation of fat and cholesterol that hardens into plaque and narrows arteries.

9 Jan 2012

GOP presidential debates touch on various health care issues

News outlets offer analysis and fact-checking after the weekend's two GOP debates. Some coverage looks ahead to South Carolina, and even further into the future.

9 Jan 2012

State governments trying new ways to cope with Medicaid costs

Despite the improving budget news, states still have tough choices to make as they continue struggling to keep up with increased demand for services - particularly for Medicaid, the state-federal health insurance program for the poor.

9 Jan 2012

CINJ receives grant to support its Breast Surgery Fellowship Program

Receiving a boost to support its Breast Surgery Fellowship Program, The Cancer Institute of New Jersey has been awarded a $75,000 grant from The Breast Cancer Alliance for academic year 2012-2013.

9 Jan 2012

ManTech International acquires Evolvent Technologies

ManTech International Corporation today completed the acquisition of Evolvent Technologies, Inc. of Herndon, Va., a focused healthcare-systems integrator with particular strength in federal healthcare systems.

9 Jan 2012

For physicians, the practice of medicine can pose business challenges

CNN reports that physicians sometimes have trouble owning a small business and the Miami Herald reports on how new technology might prove healthful.

9 Jan 2012

Neomend receives PMA from FDA for Progel Extended Applicator Spray Tip

Neomend, Inc., a leading innovator in sealant and adhesion-prevention products for the surgical marketplace, said it has received premarket approval from the U.S. Food and Drug Administration for use of the company's new Progel Extended Applicator Spray Tip.

9 Jan 2012

Perrigo signs definitive agreement to acquire assets of CanAm Care

Perrigo Company today announced that it has signed a definitive agreement to acquire substantially all of the assets of CanAm Care, a privately-held, Alpharetta, Georgia-based distributor of diabetes care products for approximately $36 million in cash.

9 Jan 2012

HDC, NeoGenomics sign worldwide licensing agreement to develop LDT

Health Discovery Corporation, a molecular diagnostics leader in the use of patent protected advanced mathematical techniques for personalized medicine, has entered into an exclusive worldwide licensing agreement with NeoGenomics, Inc. for laboratory developed tests in the Field of hematopoietic and solid tumor cancers excluding breast cancer, which was previously licensed to Quest Diagnostics and Smart Personalized Medicine and excluding cancer of the retina which was previously committed to Retinalyze, LLC.

9 Jan 2012

Cameron Health's PMA application for S-ICD System submitted to FDA

Cameron Health, Inc. announced today that it has submitted the Premarket Approval application to the Food and Drug Administration for the S-ICD System, the world's only completely subcutaneous implantable defibrillator.

9 Jan 2012

Idenix Pharmaceuticals makes progress with its HCV development pipeline

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the advancement of its hepatitis C virus development pipeline.

9 Jan 2012

DATATRAK International releases its new product, uCTMS

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the release of its new product, uCTMS.

9 Jan 2012

Sangamo BioSciences starts Phase 2 clinical studies to develop functional cure for HIV/AIDS

Sangamo BioSciences, Inc. announced today the initiation of two new Phase 2 clinical studies (SB-728-1101 and SB-728-902, Cohort 5) in its program to develop a "functional cure" for HIV/AIDS.

9 Jan 2012

Progress report on commercialization of BENLYSTA to be announced at JPMorgan Healthcare Conference

Human Genome Sciences, Inc. will today announce its priority goals for 2012 and report on progress with the commercialization of BENLYSTA (belimumab), the first approved drug for systemic lupus in 56 years, during a presentation this afternoon by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 30th Annual JPMorgan Healthcare Conference in San Francisco.

9 Jan 2012

Merck selects Idera Pharmaceuticals' TLR agonists for evaluation, use as vaccine adjuvant candidates

Idera Pharmaceuticals, Inc. today announced that Merck, known as MSD outside the United States and Canada, has selected several novel Toll-like Receptor agonists targeted to TLR7, TLR8 or TLR9 for evaluation and use as vaccine adjuvant candidates under the companies' collaboration and license agreement.

9 Jan 2012

First Edition: January 9, 2012

Today's early morning highlights from the major news organizations, including reports about the government's health law defense and the weekend's GOP presidential primary debates.

9 Jan 2012

Neurotechnology announces new line of embedded biometric technologies

Neurotechnology, a provider of high-precision biometric identification technologies, today announced their new line of embedded biometric technologies, including VeriFinger Embedded SDK for fingerprint biometrics, VeriLook Embedded SDK for face biometrics and MegaMatcher Embedded SDK for multi-biometric systems using face and fingerprints in combination.

9 Jan 2012

Pacira provides updated timing for commercial launch of EXPAREL

Pacira Pharmaceuticals, Inc. today provided updated timing for its commercial launch of EXPAREL (bupivacaine liposome injectable suspension), a non-opioid analgesic that was approved by the U.S. Food and Drug Administration (FDA) for administration into the surgical site to produce postsurgical analgesia.

9 Jan 2012

Presidio completes PPI-668 Phase 1a study on hepatitis C

Presidio Pharmaceuticals, Inc. announced today the successful completion of a Phase 1a dose-ranging assessment of PPI-668, a potent, pan-genotypic second-generation hepatitis C virus (HCV) NS5A inhibitor, in healthy volunteers and subsequent advancement to a Phase 1b assessment of the dose-related efficacy in hepatitis C patients.

9 Jan 2012